Slaying the pre-TCR beast Summary "Slaying the pre-TCR beast" likely refers to overcoming challenges and inefficiencies in traditional Request for Change (RFC) processes before implementing a more streamlined and automated Technical Change Request (Read More
Tags :Haematological cancer
Education, Research & Positions
Dual targeting of tumoral cells and immune microenvironment by blocking
Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway Summary Blocking the IL-33/IL1RL1 pathway presents a promising dual approach for cancer therapy. IL-33, released by stressed or Read More
Education, Research & Positions
CAR-T cell therapy for cancer: current challenges and future directions
CAR-T cell therapy for cancer: current challenges and future directions Summary CAR-T cell therapy has revolutionized cancer treatment, particularly for hematologic malignancies, by engineering a patient’s immune cells to target and destroy cancer cells. Read More